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ABSTRACT 
Objective: The rate of maternal and perinatal complications increases after 39 
weeks in both unselected and complicated pregnancies. The aim of this study was to 
synthesize quantitatively the evidence on the effect of elective induction of labor at 
term on the risk of Cesarean section, and maternal and perinatal outcome. 
Methods: We searched PubMed, US Registry of Clinical Trials, SCOPUS and 
CENTRAL databases from inception to August 2018. We additionally searched the 
references of retrieved articles. Eligible studies were randomized controlled trials 
including singleton uncomplicated pregnancies, in which participants were 
randomized between 39+0 and 39+6 gestational weeks to either labor induction or 
expectant management. 
The risk of bias of individual studies was assessed using the Cochrane Risk of Bias 
Tool. The overall quality of evidence was assessed per GRADE guideline. Primary 
outcomes included Cesarean section, maternal death and admission to the neonatal 
intensive care unit (NICU). Secondary outcomes included operative delivery, grade 
3/4 perineal laceration, postpartum hemorrhage, maternal infection, hypertensive 
disease of pregnancy, maternal thrombotic events, length of maternal hospital stay, 
neonatal death, need for neonatal respiratory support, cerebral palsy, length of stay 
in NICU and length of neonatal hospital stay. Pooled risk ratios (RRs) were 
calculated using random-effects models.  
Results: The meta-analysis included 5 studies (7261 cases). Labor induction was 
associated with decreased risk for Cesarean section (moderate quality of evidence; 
RR 0.86; 95% CI, 0.78–0.94; I2=0.1%), maternal hypertension (moderate quality of 
evidence; RR 0.65; 95% CI, 0.57–0.75; I2=0) and neonatal respiratory support 
(moderate quality of evidence; RR 0.73; 95% CI, 0.58–0.95; I2=0%). No significant 
effects were found for the other outcomes with available data. The main limitation of 
our analysis was that the majority of data were derived from a single large study. A 
second limitation arises from the open-label design of the studies, which may 
theoretically affect the preparedness of the attending clinician to resort to Cesarean 
section.  
Conclusions: Elective induction of labor in uncomplicated singleton pregnancies 
from 39 weeks’ gestation is not associated with maternal or perinatal complications 
and may reduce the risk of Cesarean section, hypertensive disease of pregnancy 
and need for neonatal respiratory support.  
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INTRODUCTION  
 
Population studies have shown that the prevalence of maternal and fetal 
complications increases with advancing pregnancy beyond 39 weeks of gestation1-3.  
This pattern appears to be similar both for unselected populations and groups with 
risk factors, and there is evidence that elective birth from 39 weeks minimizes 
maternal and fetal risk4, except for specific groups like growth-restricted5 and 
macrosomic6 fetuses, morbidly obese women7, women older than 44 years8, 
cholestasis of pregnancy9 and multiple pregnancy10, who may benefit from even 
earlier scheduled birth.  
In this context, induction of labor at 39 weeks has been proposed as a means to 
ensure optimal maternal and neonatal outcomes. The arguments against such a 
policy would focus on the theoretical concerns about logistics, cost, and the 
consequences of failed induction11. However, there are both retrospective12,13 and 
prospective14,15 data showing that induction at 39 weeks may in fact decrease the 
rate of complications, including cesarean section15, while there are still no cost-
effectiveness analyses of this policy. Finally, an additional factor, which is commonly 
overlooked, is women’s preferences and perceptions about induction16,17.  
As the largest to date RCT on the issue has been just published15, we performed a 
meta-analysis of randomized trials aiming to assess the impact of elective labor 
induction at 39 weeks in uncomplicated singleton pregnancies on core maternal and 
fetal outcomes.  
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METHODS 
 
This meta-analysis was structured and reported following a pre-defined protocol, 
according to the PRISMA guideline and is registered with PROSPERO 
CRD42018106768).. 
 
Eligibility criteria 
Only randomized controlled trials comparing induction of labor vs. expectant 
management in low-risk pregnant women at term were considered eligible. Studies 
reporting on high-risk pregnancies, multiple pregnancies, medically indicated 
inductions (e.g. for preeclampsia, growth restriction or macrosomia, preterm rupture 
of membranes), post-term pregnancy, or trial of labor after cesarean (TOLAC) were 
not considered eligible. Studies describing only women with a favorable or 
unfavorable Bishop score were also excluded, as recruitment of women based on 
their likelihood of successful induction would lead to selection bias.  
Types of participants: pregnant women with a singleton, low-risk pregnancy between 
39+0 and 39+6 gestational weeks.  
Types of interventions: Labor induction (any method, as defined by authors), 
between 39+0 and 39+6 weeks, vs. expectant management, i.e. anticipation of 
spontaneous onset of labor. Cases with labor induction for post-term (as defined in 
primary studies) pregnancy in the expectant arm were analyzed as expectant arm 
cases. 
 
Outcome measures  
The primary outcomes included  
1. Cesarean section 
2. Admission of the neonate to the neonatal intensive care unit (NICU)  
3. Maternal death, defined as death of the woman during pregnancy and 
puerperium 
The secondary outcomes included 
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1. Operative delivery (forceps or ventouse) 
2. Significant (grade 3/4) perineal laceration 
3. Postpartum hemorrhage (as defined in the primary studies) 
4. Maternal infection (including postpartum endometritis) 
5. Maternal hypertension 
6. Maternal thrombotic events 
7. Length of maternal hospital stay 
8. Neonatal death  
9. Need for respiratory support (neonate) 
10. Cerebral palsy (neonate) 
11. Length of stay in NICU (neonate) 
12. Length of hospital stay (neonate) 
13. Birth weight 
 
Information sources and search 
We searched PubMed, SCOPUS, the US registry of clinical trials 
(www.clinicaltrials.com) and Cochrane CENTRAL from inception to August 2018 for 
randomized controlled trials comparing induction between 39+0 and 39+6 weeks vs. 
expectant management. We used combinations of the terms “induction”, “expectant” 
and “randomize*” for the electronic searches (Table S1). We deliberately used wide 
terms to avoid missing potentially eligible trials. We complemented the searches by 
perusing the references of retrieved articles and the studies included in previous 
systematic reviews on the topic. We considered studies in European languages. 
 
Study selection and data extraction 
Search results were screened by two of the authors (SP and AS) and the full text of 
all relevant studies was reviewed. These two authors independently assessed for 
inclusion all the potential studies identified from the search strategy. Data were 
extracted using a pre-specified form. We resolved any disagreement through 
discussion or, if required, we consulted a third author (KD). 
The variables for which data were sought (in addition to pregnancy outcomes and 
inclusion/exclusion criteria) included country/countries where the studies were 
conducted, mean gestational age at randomization, mean maternal age, attrition rate 
and method of induction. 
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In case of missing and unclear data, we contacted the authors of the primary studies 
for additional information.  
 
Risk of bias of individual studies 
The risk of bias in individual studies was assessed using the Cochrane Risk of Bias 
2.0 tool18. This tool assesses potential bias in five domains: randomization process; 
deviations from intended intervention; missing outcome data; measurement of the 
outcome; selection of the reported result. For each domain, the judgment of bias may 
indicate either high or low risk of bias, of the presence of some concerns. According 
to the instructions of the tool, we allocated an overall low risk of bias for a given result 
when the risk of bias was low for all domains for this result; some concerns when 
there were some concerns in at least one domain for this result; high risk of bias 
when there was high risk in at least one domain or some concerns for multiple 
domains in a way that substantially lowered confidence in the result18. 
 
Quality of evidence 
We assessed the overall quality of the evidence for the primary and secondary 
outomes as per GRADE guideline19, 20, using the GRADEpro GD tool. Briefly, 
GRADE is a system for rating the quality of evidence in systematic reviews and 
guidelines using a scoring system across five fields, i.e. risk of bias, inconsistency, 
indirectness, imprecision and publication bias. GRADE specifies four categories for 
the quality of a body of evidence. This reflects the degree of confidence of how close 
our estimate of the effect lies to the true effect. High quality levels means that we are 
very confident that the true effect lies close to the estimate of the effect calculated by 
the meta-analysis. The level of confidence decreases with decreasing quality (high → 
moderate → low → very low) and ver low quality means that the true effect is likely to 
be substantially different from that estimated in the review20. 
 
Summary measures and synthesis of the results 
For dichotomous data, we calculated the summary risk ratios (RRs) with 95% 
confidence intervals. We calculated the mean difference (MD) for continuous 
outcomes, if they were measured in the same way between trials. We used random 
effects models (DerSimonian and Laird) for data synthesis.  
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For each outcome, we also calculated the number needed to treat (NNT), based on 
our pooled effect sizes. NNT defined by the inverse of the absolute value of the risk 
difference, and it shows the number of patients who need to be treated with one 
intervention rather than its comparator to have one more event of interest (eg, 
success). 
Between-studies heterogeneity was assessed using the I2 statistic, which is the ratio 
of between-study variance over the sum of the within- and between-study variances 
and describes the percentage of the true effect variation that is due to heterogeneity 
rather than chance (range, 0–100%). A simplistic grouping would assign descriptions 
of low, moderate and high heterogeneity to I2 values of 25, 50 and 75%, respectively 
21. 
The unit of analysis was the mother for maternal outcomes and the fetus/neonate for 
perinatal outcomes. The initial number of cases was the same for maternal and fetal 
outcomes, as only singleton pregnancies with live fetuses at randomization were 
included.  
We carried out statistical analyses using Stata 14.0 software (StataCorp College 
Station, TX). 
 
Subroup and sensitivity analyses 
We planned to perform a sensitivity analysis of studies at low risk of bias and a meta-
regression for maternal age and method of induction .  
 
Publication bias 
We planned a priori to investigate reporting biases (such as publication bias) using 
funnel plots, if there were 10 or more studies in the meta-analysis. We planned to 
assess funnel plot asymmetry visually, and will perform exploratory analyses using 
formal statistical tests if asymmetry was suggested. However, only five studies were 
included in this review, and the evaluation of publication bias was suboptimal.  
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RESULTS 
Study selection 
The flowchart of searches and study selection in shown in Figure 1. Electronic 
searches and complementary hand-searching retrieved 811 titles. After removal of 
duplicates (N=62) and exclusion of studies based on title/abstract, we downloaded 
32 cases in full text. Twenty-seven of them were excluded with reasons (Table S2). 
Two of these studies would be otherwise eligible, but were excluded because their 
participants were exclusively women with favorable22 or unfavorable Bishop scores23, 
which made them susceptible to selection bias. Eventually, five studies14,15, 24-26 (7261 
cases; 3629 allocated in induction, 3632 allocated in exectant management) were 
included in the analysis. A single study15 represented approximately 83% of all 
participants.  
 
Study characteristics 
The characteristics of studies are shown in Table 1. The largest study was performed 
in the US15, three came from the UK14,24,26 and one from Japan25. Four studies only 
included nulliparous women and one study26 included both nuliparous women and 
parous women with a faborable obstetric history. The methods of induction varied 
both across and within studies, involving amniotomy, laminariae, oxytocin and 
prostaglandins. 
 
Risks of bias within studies 
The assessment of risk per Cochrane Risk of Bias Tool v.2 is shown in Table 2. 
None of the studies was overall judged as being at a low risk of bias. All studies had 
unavoidably open-label design, which might have affected the rate of succesful 
induction and thereby a string of outcomes, starting with mode of delivery. There 
were some concerns for bias in two of the studies14,15 and the rest three studies were 
judged as being at high risk of bias24-26. A common limitation of the other three 
studies24-26 is that they provided insufficient information about the randomization 
methods, allocation concealment and handling of the results.  
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Results of individual studies 
The results of the individual studies are presented in Table S3. All five studies 
reported on the rate of cearean section; three studies14,15,25 presented information 
about NICU admision and one15 about maternal death. There was no information 
about thrombotic maternal complications, length of hospital stay, cerebral palsy, 
length of NICU stay and hospital stay for the neonate. 
 
Synthesis of the results 
Primary outcomes 
Five studies14,15,24-26 reported on cesarean section (6096 participants, 1471 women 
submitted to cesarean section).Elective induction was associated with reduced risk of 
cesarean section (RR 0.86, 95%CI 0.78-0.94, I2=0.1%) (Figure 2). The number of 
elective inductions needed to prevent one cesarean section was 32. 
Only one study15 examined maternal death. There were no deaths among the 6096 
participants. 
Three studies14,15,25 reported on NICU admission (6849 cases, 767 admissions to 
NICU). There was no significant difference between induction and expectant 
management (RR 0.90, 95%CI 0.79-1.03, I2=0%) (Figure 3).  
 
Secondary outcomes 
There was no difference between the two groups in the rates of operative delivery (5 
studies14,15,24,26, 7261 participants, 854 operative deliveries; RR 1.11, 95%CI 0.88-
1.41, I2=65.5%); grade 3-4 perineal laceration (2 studies14,15, 6794 women, 199 
women with grade 3-4 perineal laceration; RR 1.18, 95%CI 0.89-1.50, I2=0%); 
postpartum hemorrhage (2 studies14,15,  6714 women, 464 with postpartum 
hemorrhage; RR 1.06, 95%CI 0.90-1.25, I2=0%) and postpartum maternal infection 
(2 studies14,15, 6714 women, 137 with postpartum infection; RR 0.84 95%CI 0.58-
1.22, I2=9.8%). Two studies14,15 reported on hypertensive disease of pregnancy 
(6715 women, 741 with hypertensive disease of pregnancy). Elective induction at 39 
weeks was associated with a significant decrease in the risk of hypertension (RR 
0.65, 95%CI 0.57-0.75, I2=0%, NNT=21) (Figure S1).  
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 Regarding neonatal outcomes, there was no difference between the two groups in 
the risk of neonatal death (4 studies, 7126 neonates, 6 cases of neonatal death; RR 
0.57, 95% 0.12-2.71, I2=0%). Labor induction was associated with a significant 
reduction in the need for neonatal respiratory support (2 studies14,15, 6714 neonates, 
250 needed support; RR 0.73 95%CI 0.58-0.95, I2=0%) (Figure S2). Neonates born 
after induction had significantly lower mean birth weight than those in the expectant 
group (3 studies14,15,26, 6942 neonates; pooled MD -81 g, 95%CI -100 g to -63 g, 
I2=0%). 
 
Subgroup and sensitivity analyses 
There was insufficient published data to perform the prespecified subgroup and 
sensitivity analyses. 
 
Overall quality of the evidence 
The overall quality of the evidence (Table 3) was moderate for cesarean section, 
maternal hypertension and need for neonatal respiratory support; low for NICU 
admission, grade 3-4 perinatal lacerations and postpartum maternal infection, and 
very low for operative vaginal delivery and neonatal death. All outcomes were 
downgraded by one level for bias, as all evidence was derived exclusively from 
studies at concern or at high risk of bias. Several outcomes were further downgraded 
by one level for imprecision, as the 95%CIs of their pooled effect sizes included the 
unit; neonatal death was downgraded by two levels, as the number of events (n=6) 
was quite small to reach any robust conclusion. Operative delivery was also 
downgraded by one level because of inconsistency, as the corresponding studies 
indicated heterogeneous direction of effect.  
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DISCUSSION 
Summary of evidence 
Our synthesis of evidence from randomized controlled trials showed that, compared 
to expectant management, elective induction of labor at 39 weeks in uncomplicated 
singleton pregnancies is associated with reduced risk of cesarean section (RR 0.86, 
moderate quality of evidence), reduced risk of maternal hypertension (RR 0.65, 
moderate quality of evidence) and reduced need for neonatal respiratory support (RR 
0.73, moderate quality of evidence). There is no indication that elective induction 
from 39 weeks is associated with an adverse effect on maternal or neonatal 
outcomes.  
Interpretation of the results 
The rationale supporting elective induction at 39 weeks is that population data 
demonstrate an increase in the rate of perinatal and maternal complications in both 
unselected and complicated pregnancies after 38-39 weeks1-3. The major 
counterarguments against such a policy have been the concerns for failed induction 
and the concomitant risk for maternal and neonatal complications, mostly arising 
from retrospective studies27, 28.  
Our results do not support these concerns. Elective induction at 39 weeks may, in 
fact, result in a relative reduction of the rate of caesarean sections, from 
approximately 22% in expectant management to approximately 19% with induction 
(NNT 32). This does not appear to happen at the expense of an increase in the rate 
of operative deliveries. A possible explanation is that 39 weeks is the optimal time for 
induction. Women who continue their pregnancy beyond 39 weeks become 
progressively less likely to succeed after induction29. This may reflect increasing 
rates of failure to progress in labour (as the foetus becomes larger there is a higher 
risk of cephalopelvic disproportion) and increasing risks of fetal distress due to a 
simultaneous decrease in placental reserve30. In our analysis, the mean birthweight 
of neonates in the induction group was approximately 80 g lower than those in the 
expectant management group, although it is not clear if this difference affected the 
chance of successful induction. 
We found that labour induction at 39 weeks can decrease the risk of hypertensive 
disease of pregnancy, from approximately 13% with expectant management to 
approximately 9% (NNT 21). We hypothesize that the beneficial effect of induction at 
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39 weeks is mostly mediated though the prevention of hypertensive complications 
that would manifest later, should pregnancy continue31, 32.  
A third potentially beneficial effect of induction was the reduced need for respiratory 
support of the neonate, from approximately 4% with expectant management to 
approximately 3% when performing induction of labor at 39 weeks (NNT 83). A 
retrospective study of 5000 non-anomalous term fetuses found that the presence of 
meconium increases the risk for respiratory distress by 3.3 times and caesarean 
section by 4.2 times33 and it is likely that the improvement in respiratory outcomes 
may be related to a reduction in meconium exposure before birth.   
 
Strengths and limitations 
Our strict selection methodology ensures that our results describe a well-defined 
population of singleton uncomplicated pregnancies between 39+0 and 39+6 weeks. 
In this context, we excluded two otherwise eligible studies, one of them only including 
women with favorable22 and one including only women with unfavorable cervix 23, as 
both of them would be at theoretical risk of selection bias. Our focus on singleton 
uncomplicated pregnancies at 39 weeks differentiates our meta-analysis from 
previous systematic reviews34-37, which analyzed term pregnancies (i.e. ≥37 weeks) 
as a group34-37, included all indications for induction in their main analyses34-37, or 
only assessed the impact of induction on cesarean section rate34. Moreover, none of 
the previous meta-analyses included the data from the ARRIVE trial15, which 
contributes by more than 80% of the total sample for our target population. 
The main limitation of our analysis was that most of the data was derived from a 
single large study15, which, depending on the outcome ranged from 29% to 97%. A 
second limitation arises from the unavoidably open-label/unblinded design of all 
included studies, which might affect the preparedness of the attending clinician to 
resort to cesarean section. Although this is mostly a theoretical concern, and it is not 
possible to safely predict its direction of effect, we downgraded all outcomes by one 
degree for bias. There were no data for many of our pre-defined outcomes, and not 
sufficient data to perform subgroup and sensitivity analyses. The methods of 
induction differed across and within studies, preventing us from exploring the 
potential impact of different methods on the observed results; previous pooled results 
indicate that cervical ripening before induction of contractions increases the likelihood 
of success34. Moreover, there was no information amenable to quantitative synthesis 
from the included studies to gauge the impact of systematic induction on women´s 
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satisfaction and experience, although data from the largest included study15 indicate 
similar scores of perceived control during childbirth in the two groups. Finally, the 
small number of included studies did not allow a formal evaluation of publication bias; 
however, this is likely to be low, judging from the dispersion of the estimates even in 
smaller studies. 
 
Generalizability and applicability 
Almost all data come from studies of nulliparous women having an uncomplicated 
singleton pregnancy between 39+0 and 39+6 weeks. Therefore, our results are 
applicable to such women, and their generalization to the entire population is 
uncertain. 
Although the US Society for Maternal and Fetal Medicine issued an instant statement 
proposing that it is reasonable to offer elective IOL to low-risk, nulliparous women at 
or beyond 39 weeks 38, there are still significant unresolved issues. Thus, there are 
no data on how such a policy would affect the logistics and cost of maternity care. 
Also, the current studies do not provide information about the long-term 
neurodevelopmental impact of induction at 39 weeks. This is an important 
consideration given the retrospective observational data showing that the nadir of 
special education need is reached for children born at 40-41 weeks39,40. In this 
context, the most likely subgroup to be benefited from an induction policy might be 
nulliparous women with risk factors for hypertensive, other medical or fetal 
complications in pregnancy. 
 
Conclusions  
There is moderate quality evidence that elective induction of labor in uncomplicated 
singleton pregnancies from 39 weeks may be associated with reduced risk of 
cesarean section, maternal hypertension and need for respiratory support in the 
neonate. Unresolved issues, should systematic induction be adopted, involve 
logistics, cost, the preferences of women and possibly the long-term 
neurodevelopmental outcome of the offspring.  
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Legends for figures 
Figure 1. Flowchart of study selection of randomized controlled trials for meta-
analysis. 
Figure 2. Relative risks for cesarean section in selective labor induction at 39 weeks 
and expectant management. 
Figure 3. Relative risks for admission to the neonatal intensive care unit (NICU) in 
selective labor induction at 39 weeks and expectant management. 
 
 
Supplemental Figure S1. Relative risks for hypertensive disorders of pregnancy in 
selective labor induction at 39 weeks and expectant management 
Supplemental Figure S2. Relative risks for neonatal respiratory support in selective 
labor induction at 39 weeks and expectant management 
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811  records identified 
through database searching 62 duplicates removed 
 
32 full text articles assessed 
for eligibility 
27 studies excluded with reasons: 
restriction based on Bishop score (n=2) 
            intervention before 39 weeks (n=2) 
            intervention after 40 weeks (n=17) 
only post-term pregnancies included (n=6)   
5 studies included  
in meta-analysis 
 
811 records identified through 
database searching 
 
 …. records excluded based on title and 
abstract 
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Figure 2. Relative risks for cesarean section in selective labor induction at 39 weeks 
and expectant management. 
 
Figure 3. Relative risks for admission to the neonatal intensive care unit (NICU) in 
selective labor induction at 39 weeks and expectant management. 
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selective labor induction at 39 weeks and expectant management 
Supplemental Figure S2. Relative risks for neonatal respiratory support in selective 
labor induction at 39 weeks and expectant management 
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Table 1. Characteristics of the included studies (PICOS) 
Stud
y 
No 
of 
patie
nts 
Inclusion 
criteria 
Exclusio
n criteria 
Outcomes Intervent
ion 
Low-
risk 
definit
ion 
T1 T2 
Grob
man 
2018 
 
6,09
6 
 
Low-risk 
nulliparou
s women; 
live 
singleton 
fetus in 
vertex 
presentati
on; no 
contraindi
cation to 
vaginal 
delivery, 
no 
planned 
cesarean 
delivery; 
certain 
gestation
al age. 
 
Women in 
labor or 
with 
prematur
e rupture 
of 
membran
es 
or vaginal 
bleeding 
at  
38+0 to 
38+6 
Cesarean 
delivery; perinatal 
death; need for 
respiratory 
support within 72 
hours after birth; 
Apgar score; 
hypoxic–ischemic 
encephalopathy; 
seizure; infection; 
meconium 
aspiration 
syndrome; birth 
trauma; 
intracranial or 
subgaleal 
hemorrhage; 
hypotension 
requiring 
vasopressor 
support. Birth 
weight, duration 
of respiratory 
support, 
cephalohematom
a, 
shoulder 
dystocia, 
transfusion of 
blood 
products,hyperbili
rubinemia 
requiring 
phototherapy 
or exchange 
transfusion, 
hypoglycemia 
requiring 
intravenous 
therapy, 
admission to the 
neonatal 
intermediate or 
intensive care 
unit, and 
length of 
hospitalization. 
Hypertensive 
disorders of 
pregnancy, 
indication for 
cesarean 
delivery, 
operative vaginal 
delivery, 
indication for 
operative vaginal 
delivery, uterine 
incisional 
extensions during 
cesarean 
Iinduction 
of labor 
at 39+0  
to 39+4. 
No 
specific 
induction 
protocol 
mandate
d 
 
Absen
ce of 
any 
conditi
on 
consid
ered to 
be a 
matern
al or 
fetal 
indicati
on 
for 
deliver
y 
before 
40 
weeks 
5 days 
Under
go 
inducti
on of 
labor 
at 
39+0 
to 
39+4  
Elective 
delivery 
before 
40+5  
and  
no later 
than 
42+2  
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delivery, 
chorioamnionitis, 
3- or 4-degree 
perineal 
laceration, 
postpartum 
hemorrhage, 
postpartum 
infection, venous 
thromboembolis
m, 
number of hours 
in the labor and 
delivery unit, 
length of 
postpartum 
hospital stay, 
admission to the 
intensive care 
unit, and 
maternal death. 
Walk
er 
2016 
618 Nulliparou
s women, 
35 years 
of age or 
older on 
their 
expected 
due date, 
with  a 
singleton 
live fetus 
in a 
cephalic 
presentati
on.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fetal 
congenita
l 
abnormali
ty; 
contraindi
cation 
to labor, 
vaginal 
delivery 
or 
expectant 
managem
ent  
History of 
myomect
omy, 
certain 
gestation
al age 
 
Cesarean 
delivery. Method 
of delivery other 
than cesarean 
section, onset of 
labor, intrapartum 
complications, 
postpartum 
complications 
(e.g., systemic 
infection or the 
need for 
a blood 
transfusion). 
Live birth or 
stillbirth, birth 
weight, 
admission to a 
neonatal 
intensive care 
unit, birth trauma, 
and 
two composite 
outcomes for 
serious neonatal 
complications 
(direct trauma 
and hypoxia).  
Maternal 
expectations and 
experience of 
childbirth 
Local 
policies 
for 
induction 
of 
labor. 
N/A Inducti
on of 
labor  
betwe
en  
39
+0
 
and 
39
+6
  
compl
eted 
weeks  
 
Await 
the 
spontan
eous 
onset of 
labour 
until 42 
weeks 
unless 
inductio
n was 
required 
earlier 
for 
medical 
reasons
.  
 
Aman
o 
1999 
135 Uncompli
cated 
nullipara 
in 38
+6
 
No 
informatio
n 
Normal 
spontaneous 
delivery, vacuum 
extraction,forceps
, cesarean 
section, 
incidence of 
pathological 
FHR, 
resuscitation in 
labor Apgar score 
in 1
st
 minute, 
Umbilical artery 
pH, NICU 
Laminari
a tents ±  
oral 
administr
ation± 
rupture of 
membran
es± 
oxytocin 
or PGF2, 
under 
direct 
CTG 
monitorin
N/A Inducti
on of 
labor 
at 39 
compl
eted 
weeks 
Spontan
eous 
onset of 
labor 
was 
awaited 
until 42 
complet
ed 
weeks 
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admission, 
meconium-
stained amniotic 
fluid, maternal 
blood loss 
 
 
g. 
Epidural 
or 
balanced 
anesthesi
a used. 
Marti
n 
1978 
184 Past 
and/or 
present 
pregnanci
es were 
obstetrica
lly 
normal, 
booking 
in the 
index 
pregnanc
y no later 
than the 
18th 
week,  
menstrual 
cycle did 
not 
exceed 
<36 days, 
no 
pregnanc
y for at 
least 
three 
months 
before the 
last 
menstrual 
period, 
size of 
the uterus 
at 
booking 
correspon
ded to the 
period of 
amenorrh
oea 
N/A Vaginal delivery, 
forceps delivery, 
caesarean 
section, length of 
labor, 
unexplained 
postpartum 
pyrexia, demand  
for analgesia, 
meconium 
staining for 
amniotic fluid, 
Apgar score at 1
st
 
and 5
th
 minute, 
stillbirth, neonatal 
jaundice 
Amnioto
my ± 
intraveno
us 
oxytocin. 
 
N/A Inducti
on of 
labor 
at 
at 39 
weeks  
 
Wait for 
spontan
eous 
onset of 
labour 
until 42 
weeks, 
unless 
inductio
n was 
required 
earlier 
for 
medical 
reasons
. 
Cole 
1975 
228 Primigravi
dae 
aged 18-
30 years 
or women 
of 1, 2, or 
3 parity 
aged 18-
35 years 
who had 
had 
normal 
pregnanci
es without 
any 
previous 
obstetric 
abnormali
ty. 
Certain 
N/A Vaginal delivery, 
forceps delivery, 
caesarean 
section, length of 
labor, dose of 
pethidine, 
number of 
epidurals, blood 
loss after vaginal 
delivery, perinatal 
loss, meconium 
staining in labour, 
first stage fetal 
heart irregularity, 
Apgar score, birth 
weight, 
unsuspected 
SGA, transient 
respiratory 
distress, neonatal 
Amnioto
my 
followed 
immediat
ely by 
oxytocin 
at 
increasin
g 
doses 
using the 
Cardiff 
pump. 
N/A Inducti
on of 
labour 
betwe
en 39 
and 
40 
weeks  
 
Await 
the 
spontan
eous 
onset of 
labour 
until 41 
weeks 
unless 
inductio
n was 
required 
earlier 
for 
medical 
reasons
. 
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gestation
al age. 
jaundice 
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eTable 2: Risk of bias table, as per Cochrane Collaboration Risk of Bias Tool II.    Grobman et al. 2018 Walker et al. 2016 Amano et al. 1999 Martin et al. 1978 Cole 1975 Bias arising from the 
randomization 
process 
1.1 Was the allocation sequence random? Y Y N Y Y 
1.2 Was the allocation sequence concealed until participants were 
recruited and assigned to intervention? 
PY PY N PY NI 
1.3. Were there baseline imbalances that suggest a problem with the 
randomization process? 
N N N N 
 
N 
Risk of bias judgement Low Low High Some concerns Some concerns 
Bias due to 
deviations from 
intended 
interventions 
2.1. Were participants aware of their assigned intervention during the 
trial? 
Y Y Y Y Y 
2.2. Were carers and trial personnel aware of their assigned intervention 
during the trial? 
Y Y Y Y Y 
2.3. If Y/PY/NI to 2.1 or 2.2: Were there deviations from intended 
intervention beyond what would be expected in usual practice? 
N N N N N 
2.4.  If Y/PY/NI to 2.3: Were these deviations from intended intervention 
unbalanced between groups and likely to have affected the outcome? 
PN PN PN PN N 
2.5. Were any participants analysed in a group different from the one to 
which they were assigned? 
Y Y Y Y NI 
2.6.  If Y/PY/NI to 2.5. Was there potential for a substantial impact (on 
the estimated effect of intervention) of analysing participants in the 
wrong group? 
N PN PN PY PN 
Risk of bias judgement Low Some concerns Some concerns Some concerns Some concerns 
Bias due to 
missing 
outcome data 
3.1. Were outcome data available for all, or nearly all, participants 
randomized? 
Y Y Y Y Y 
3.2.  If Y/PY/NI to 3.1: Are the proportions of missing outcome data and 
reasons for missing outcome data similar across intervention groups? 
Y Y N N Y 
3.3.  If Y/PY/NI to 3.1: Is there evidence that results were robust to the 
presence of missing outcome data? 
Y Y PY PY PY 
Risk of bias judgement Low Low Some concerns Some concerns Low 
Bias in 
measurement 
of the outcome 
4.1. Were outcome assessors aware of the intervention received by 
study participants? 
Y Y Y Y Y 
4.2.  If Y/PY/NI to 4.1: Was the assessment of the outcome likely to be 
influenced by knowledge of intervention received? 
PN PN PN PN PN 
Risk of bias judgement Some concerns Some concerns Some concerns Some concerns Some concerns 
Bias in 
selection of the 
reported result 
Are the reported outcome data likely to have been selected, on the 
basis of the results, from… 
5.1. …multiple outcome measurements (e.g scales, definitions, time 
points) within the outcome domain? 
 
 
N 
 
 
N 
 
 
NI 
 
 
NI 
 
 
NI 
5.2. …multiple analysis of the data? N N NI NI NI 
Risk of bias judgement Low Low Some concerns Some concerns Some concerns 
Overall bias Risk of bias judgement Some concerns Some concerns High High High 
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eTable 3: Summary of findings:  Labor induction at 39 weeks in singleton uncomplicated pregnancies vs. to expectant management  Patient or population: reducing the rates of cesarean section  Setting:  
Intervention: labor induction at 39w0d to 39w6d  
Comparison: expectant management up to 41-42w 
 
Outcomes Anticipated absolute effects
*
 (95% CI) NNT Relative effect 
(95% CI) 
№ of participants  
(studies) 
Certainty of 
the evidence 
(GRADE) 
Risk with expectant 
management 
Risk with labor 
induction at 39 
weeks 
Cesarean section  21.8% 18.7% 
(17.0-20.5%) 
32 
(21-77) 
RR 0.86 
(0.78 to 0.94) 
7,261 
(5 RCTs) 
⨁⨁⨁◯ 
MODERATE 
a
 
NICU admission  11.8% 10.6% 
(9.3-12.1%) 
- RR 0.90 
(0.79 to 1.03) 
6,849 
(3 RCTs) 
⨁⨁◯◯ 
LOW 
a,b
 
Operative delivery  11.4% 11.8% 
(9.4-14.7%) 
- RR 1.03 
(0.82 to 1.29) 
7,126 
(4 RCTs) 
⨁◯◯◯ 
VERY LOW 
a,b,c
 
Grade 3/4 perinatal lacerations  2.7% 3.2% 
(2.4-4.1%) 
- RR 1.18 
(0.89 to 1.50) 
6,714 
(2 RCTs) 
⨁⨁◯◯ 
LOW 
a,b
 
Postpartum hemorrhage  6.8% 7.2%  
(6.1-8.5%) 
- RR 1.06 
(0.90 to 1.25) 
6,714 
(2 RCTs) 
⨁⨁◯◯ 
LOW 
a,b
 
Postpartum maternal infection  2.2% 1.9% 
(1.3-2.7%) 
- RR 0.84 
(0.58 to 1.22) 
6,714 
(2 RCTs) 
⨁⨁◯◯ 
LOW 
a,b
 
Maternal hypertension  13.4% 8.7% 
(7.6-10.0%) 
21 
(17-29) 
RR 0.65 
(0.57 to 0.75) 
6,715 
(2 RCTs) 
⨁⨁⨁◯ 
MODERATE 
a
 
Neonatal death  0.1% 0.1% 
(0.0-0.3%) 
- RR 0.57 
(0.12 to 2.71) 
7,116 
(4 RCTs) 
⨁◯◯◯ 
VERY LOW 
a,b,d
 
Neonatal respiratory support  4.3% 3.1% 
(2.5-4.1%) 
83 
(56-500) 
RR 0.73 
(0.58 to 0.95) 
6,714 
(2 RCTs) 
⨁⨁⨁◯ 
MODERATE 
a
 
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is 
substantially different 
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect 
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention 
(and its 95% CI).  
CI: Confidence interval; RR: Risk ratio; NNT = number needed to treat (calculated only when significant difference was observed) 
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Explanations 
a. Data is exclusively derived from studies at concern for bias or at high risk of bias  
b. The 95% CI for the pooled effect sizes include the unit  
c. Different direction of effect across the studies  
d. Very small number of events  
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